Picture of DocMorris AG logo

DOCM DocMorris AG News Story

0.000.00%
ch flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeSmall CapTurnaround

Brief: Docmorris Achieves Revenue Growth In Q4 2023, Confirms Outlook

Jan 16 (Reuters) - DOCMORRIS AG  DOCM.S :
    * ACHIEVES SIGNIFICANT REVENUE GROWTH IN THE FOURTH QUARTER
OF
2023 AND CONFIRMS INFLECTION POINT BY INCREASING ACTIVE CUSTOMER
BASE
    * REVENUE OUTLOOK ACHIEVED AT UPPER END IN 2023
    * OUTLOOK CONFIRMED
    * E-PRESCRIPTION MANDATORY AND SUCCESSFULLY INTRODUCED
THROUGHOUT
GERMANY
    * 14.3 PER CENT REVENUE GROWTH IN Q4 OF 2023 AND INCREASE IN
ACTIVE CUSTOMER BASE TO 9.1 MILLION
    * FOR 2024, DOCMORRIS CONTINUES TO EXPECT TO BREAK-EVEN ON
ADJUSTED EBITDA, EXCLUDING E-PRESCRIPTIONS
    * FY EXTERNAL REVENUE AMOUNTED TO CHF 1,038.0 MILLION
    * IN MAIN MARKET OF GERMANY, EXTERNAL REVENUE IN Q4 ROSE BY
14.7
PER CENT IN LOCAL CURRENCY COMPARED TO PREVIOUS YEAR

Source text for Eikon:  ID:nEQ6PFH2ba 
Further company coverage:  DOCM.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on DocMorris AG

See all news